Treatment and survival outcomes based on income group for selected subgroups
| Overall | Low income | High income | ||
|---|---|---|---|---|
| Clinical stage I-III only (all subtypes) | ||||
| Number | 1,937 | 459 | 1,478 | |
| 2-year overall mortality | 1,332 (68.8) | 350 (76.3) | 982 (66.4) | < 0.001 |
| 5-year overall mortality | 1,549 (80.0) | 395 (86.1) | 1,154 (78.1) | < 0.001 |
| 2-year cancer specific mortality | 1,224 (63.2) | 323 (70.4) | 901 (61.0) | < 0.001 |
| 5-year cancer specific mortality | 1,419 (73.3) | 364 (79.3) | 1,055 (71.4) | 0.001 |
| 2-year non-cancer mortality | 108 (5.6) | 27 (5.9) | 81 (5.5) | 0.833 |
| 5-year non-cancer mortality | 130 (6.7) | 31 (6.8) | 99 (6.7) | > 0.999 |
| Clinical stage IV only (all subtypes) | ||||
| Number | 1,309 | 295 | 1,014 | |
| 2-year overall mortality | 1,213 (92.7) | 278 (94.2) | 935 (92.2) | 0.294 |
| 5-year overall mortality | 1,263 (96.5) | 288 (97.6) | 975 (96.2) | 0.303 |
| 2-year cancer specific mortality | 1,153 (88.1) | 261 (88.5) | 892 (88.0) | 0.893 |
| 5-year cancer specific mortality | 1,201 (91.7) | 271 (91.9) | 930 (91.7) | > 0.999 |
| 2-year non-cancer mortality | 60 (4.6) | 17 (5.8) | 43 (4.2) | 0.346 |
| 5-year non-cancer mortality | 62 (4.7) | 17 (5.8) | 45 (4.4) | 0.431 |
| Intrahepatic clinical stage I-III only | ||||
| Number | 905 | 198 | 707 | |
| 2-year overall mortality | 598 (66.1) | 151 (76.3) | 447 (63.2) | 0.001 |
| 5-year overall mortality | 699 (77.2) | 168 (84.8) | 531 (75.1) | 0.005 |
| 2-year cancer specific mortality | 552 (61.0) | 144 (72.7) | 408 (57.7) | < 0.001 |
| 5-year cancer specific mortality | 645 (71.3) | 161 (81.3) | 484 (68.5) | 0.001 |
| 2-year non-cancer mortality | 46 (5.1) | 7 (3.5) | 39 (5.5) | 0.348 |
| 5-year non-cancer mortality | 54 (6.0) | 7 (3.5) | 47 (6.6) | 0.143 |
| Intrahepatic clinical stage IV only | ||||
| Number | 770 | 163 | 607 | |
| 2-year overall mortality | 709 (92.1) | 153 (93.9) | 556 (91.6) | 0.431 |
| 5-year overall mortality | 743 (96.5) | 160 (98.2) | 583 (96.0) | 0.288 |
| 2-year cancer specific mortality | 682 (88.6) | 145 (89.0) | 537 (88.5) | 0.972 |
| 5-year cancer specific mortality | 715 (92.9) | 152 (93.3) | 563 (92.8) | 0.961 |
| 2-year non-cancer mortality | 27 (3.5) | 8 (4.9) | 19 (3.1) | 0.392 |
| 5-year non-cancer mortality | 28 (3.6) | 8 (4.9) | 20 (3.3) | 0.459 |
| Perihilar clinical stage I-III only | ||||
| Number | 733 | 180 | 553 | |
| 2-year overall mortality | 540 (73.7) | 139 (77.2) | 401 (72.5) | 0.251 |
| 5-year overall mortality | 627 (85.5) | 161 (89.4) | 466 (84.3) | 0.111 |
| 2-year cancer specific mortality | 504 (68.8) | 128 (71.1) | 376 (68.0) | 0.489 |
| 5-year cancer specific mortality | 581 (79.3) | 147 (81.7) | 434 (78.5) | 0.418 |
| 2-year non-cancer mortality | 36 (4.9) | 11 (6.1) | 25 (4.5) | 0.51 |
| 5-year non-cancer mortality | 46 (6.3) | 14 (7.8) | 32 (5.8) | 0.435 |
| Perihilar clinical stage IV only | ||||
| Number | 421 | 103 | 318 | |
| 2-year overall mortality | 397 (94.3) | 96 (93.2) | 301 (94.7) | 0.759 |
| 5-year overall mortality | 408 (96.9) | 99 (96.1) | 309 (97.2) | 0.834 |
| 2-year cancer specific mortality | 378 (89.8) | 91 (88.3) | 287 (90.3) | 0.714 |
| 5-year cancer specific mortality | 389 (92.4) | 94 (91.3) | 295 (92.8) | 0.774 |
| 2-year non-cancer mortality | 19 (4.5) | 5 (4.9) | 14 (4.4) | > 0.999 |
| 5-year non-cancer mortality | 19 (4.5) | 5 (4.9) | 14 (4.4) | > 0.999 |
| Distal clinical stage I-III only | ||||
| Number | 299 | 81 | 218 | |
| 2-year overall mortality | 194 (64.9) | 60 (74.1) | 134 (61.5) | 0.058 |
| 5-year overall mortality | 223 (74.6) | 66 (81.5) | 157 (72.0) | 0.128 |
| 2-year cancer specific mortality | 168 (56.2) | 51 (63.0) | 117 (53.7) | 0.191 |
| 5-year cancer specific mortality | 193 (64.5) | 56 (69.1) | 137 (62.8) | 0.382 |
| 2-year non-cancer mortality | 26 (8.7) | 9 (11.1) | 17 (7.8) | 0.501 |
| 5-year non-cancer mortality | 30 (10.0) | 10 (12.3) | 20 (9.2) | 0.552 |
| Distal clinical stage IV only | ||||
| Number | 118 | 29 | 89 | |
| 2-year overall mortality | 107 (90.7) | 29 (100) | 78 (87.6) | 0.105 |
| 5-year overall mortality | 112 (94.9) | 29 (100) | 83 (93.3) | 0.343 |
| 2-year cancer specific mortality | 93 (78.8) | 25 (86.2) | 68 (76.4) | 0.39 |
| 5-year cancer specific mortality | 97 (82.2) | 25 (86.2) | 72 (80.9) | 0.712 |
| 2-year non-cancer mortality | 14 (11.9) | 4 (13.8) | 10 (11.2) | 0.969 |
| 5-year non-cancer mortality | 15 (12.7) | 4 (13.8) | 11 (12.4) | > 0.999 |
Values are presented as number (%).